Regulatory
Premarket Approval(PMA)
In one line
FDA's most stringent device marketing application, required for high-risk Class III devices.
Definition
Premarket Approval (PMA) is the FDA process of scientific and regulatory review to evaluate the safety and effectiveness of Class III medical devices. PMA is the most stringent type of device marketing application required by the FDA.
Unlike a 510(k), a PMA does not rely on comparison to a predicate. The sponsor must provide valid scientific evidence, usually including clinical investigation data, that gives reasonable assurance of safety and effectiveness. FDA may convene an advisory panel, inspects manufacturing facilities before approval, and later changes to an approved device often need a PMA supplement under 21 CFR 814.39.
Why it matters
PMA submissions must include valid scientific evidence, typically from adequate and well-controlled clinical investigations, that the device is safe and effective for its intended use. They also undergo a Pre-Approval Inspection (PAI) of the manufacturing facility. Post-approval, PMA devices remain subject to conditions of approval, post-approval studies, and annual reports.
Common pitfalls
- •Assuming a 510(k) pathway will work for novel high-risk devices. Class III devices default to PMA unless reclassified.
- •Underestimating the manufacturing inspection component (PAI); GMP nonconformities can delay approval regardless of clinical data quality.
- •Building a clinical program without an early FDA Pre-Submission (Q-Sub) meeting to align on endpoints, control, and statistical plan.
- •Confusing PMA approval with 510(k) clearance in labeling and marketing materials.
Sources
- Premarket Approval (PMA) · FDA
- 21 CFR Part 814 · eCFR
- PMA Application Contents · FDA